SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Edison Oncology at SNO 2026
Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website
Edison Oncology brings 3 presentations to SNO 2026 in Philadelphia. Edison Oncology's program centres on EO1001, an oral brain-penetrating pan-ErbB inhibitor, including updated early trial results. Preclinical work on a second agent in tumor models also features.
| Organization | SNO 2026 Attendance |
|---|---|
Edison Oncology Menlo Park, CA | |
A clinical-stage biopharmaceutical company developing biomarker-driven cancer therapies, including brain-penetrant candidates for brain tumors. | Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm |
Find decision makers at Edison Oncology
Tell us what you sell and we’ll find the people at Edison Oncology most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction